Pharma/Biotech - Page 1 | TalkMarkets
All Posts > Content under Pharma/Biotech
1 to 16 of 2652 Posts
1 2 3 ... 166
No More "Business As Usual" For Europe's Petrochemicals Companies
Article By: Paul Hodges
Sunday, October 14, 2018 9:17 AM EDT
Europe's petrochemical sector must prepare now for the combined impact of trade wars, new US polymer start-ups, the circular economy and Brexit. That was the clear message from last week's European Petrochemical Association meeting in Vienna.
Read
Banks Provide Positive Start To Q3 Earnings Season
Article By: Sheraz Mian
Saturday, October 13, 2018 5:51 PM EDT
Bank stocks have been notable laggards in recent quarters, with market participants preferring the faster growing technology stocks to these seemingly boring companies. Banks are boring, but they have a lot going for them.
In this article: JNJ, SLB, NFLX
Read
Week In Review: Biosense Exercises $75 Million Option For China Rights To Neovacs' Lupus Immunotherapy
Article By: ChinaBio® Today
Saturday, October 13, 2018 4:59 PM EDT
Biosense Global, a New Jersey-Suzhou in-licensing company, exercised a $75 million option for China rights to an active lupus immunotherapy developed by Neovacs, following a successful Phase II trial of the therapeutic vaccine, IFNalpha Kinoid.
In this article: MEIP, BGNE
Read
Corium Announces Agreement For Gurnet Point Capital To Purchase All Outstanding Shares
Article By: NASDAQ GlobeNewswire
Friday, October 12, 2018 12:00 AM EDT
Total transaction valued in excess of $500 million, representing a 50% premium.
In this article: CORI
Read
Walgreens (WBA) Q4 Earnings Top Estimates, Revenues Lag
Article By: Zacks Investment Research
Thursday, October 11, 2018 12:31 PM EDT
Walgreens Boots Alliance, Inc. WBA reported adjusted earnings per share (EPS) of $1.48 for fourth-quarter fiscal 2018, up 12.9% year over year (same at constant exchange rate). The figure surpassed the Zacks Consensus Estimate of $1.44.
In this article: WBA Also: MASI, AMED, ISRG
Read
Puma Biotech: Is It Time For This Kitty To Roar?
Article By: TipRanks
Wednesday, October 10, 2018 10:29 PM EDT
Puma is an oncology company with drug Nerlynx approved for HER2 positive adjuvant breast cancer. But the market has yet to appreciate the drug’s full potential.
In this article: PBYI
Read
A Drug Giant Whose Dividend Safety Isn’t As Bad As It Looks
Article By: Marc Lichtenfeld
Wednesday, October 10, 2018 7:30 PM EDT
Investors tend to buy large pharmaceutical companies because of their safety.
In this article: PFE
Read
Altimmune Announces $25 Million Registered Direct Offering
Article By: NASDAQ GlobeNewswire
Monday, October 8, 2018 11:00 PM EDT
Altimmune, Inc. today announced it has entered into a purchase agreement with several institutional investors for the purchase of common units and pre-funded units for a combined total of 4,629,630 units in a registered direct offering.
In this article: ALT
Read
The Week In Charts: Your Trading Success Might All Boil Down To This One Thing
Video By: Dave Landry
Sunday, October 7, 2018 7:36 AM EDT
In this episode, Dave discusses how your trading success could boil down to just two words. And, last but not least, he fielded your trading questions and analyzed your favorite stock picks.
In this video: ANET, UROV, MRNS, SQ, TLT, SPY, COMP, IWM, TNX, NERV, USO, UUP, XLF
Watch
Week In Review: Shanghai Henlius To File For Hong Kong IPO At Valuation Of Over $1 Billion
Article By: ChinaBio® Today
Saturday, October 6, 2018 5:57 PM EDT
Shanghai Fosun Pharma announced it will seek a Hong Kong IPO for Shanghai Henlius Biotech, its monoclonal antibody JV subsidiary The company was established to develop mAb biosimilar drugs, bio-betters and novel mAbs.
In this article: GILD, CBMG
Read
Einhorn's Greenlight Exits Apple, Buys Altice USA And BT Group
Article By: The Fly
Friday, October 5, 2018 7:24 PM EDT
David Einhorn's Greenlight Capital sold the last of its Apple (AAPL) long position on August 31 at a price of $228 per share, the firm announced in its quarterly letter sent to investors.
In this article: BT, MLM, TDG, AAPL, MU, MYL, TSLA, ATUS
Read
AskSlim Market Week - Friday, October 5
Video By: Steve Miller
Friday, October 5, 2018 7:08 PM EDT
The stock market finally gave way to some declines late in the week as interest rates rose to a level that spooked investors.
In this video: AEO, BBY, DAL, LLY, VLO, AMZN, DECK, TSLA, PSX, SPX, GPRO
Watch
3 Small Cap Biotechs With Upcoming Catalysts
Article By: Scott Matusow
Monday, October 1, 2018 8:21 PM EDT
Catalyst Trading in biotech stocks can be very profitable. Often times, many catalyst events are over looked by the market, especially when it comes to small cap biotech.
In this article: AFMD, BLRX, SNDX Also: BMY, FPRX
Read
5 Best Biotech Stocks To Buy In October
Article By: Zacks Investment Research
Monday, October 1, 2018 11:50 AM EDT
Here are five stocks that are expected to move north following successful drug developments.
In this article: CSBR, CYDY, INFI, NKTR, ZTS Also: AMRN, ACAD, SRPT, GILD, AGN
Read
E Stock Analysis Of The Week: Abiomed
Video By: Dr. Joseph Belmonte
Monday, October 1, 2018 12:30 AM EDT
Abiomed just won't stop going up. New numbers have propelled this stock up 21% in the past two weeks.
In this video: ABMD
Watch
E Johnson & Johnson: Recession Safety, Growth And Valuation
Article By: SureDividend
Sunday, September 30, 2018 10:26 AM EDT
it is a shame to miss the exceptional long-term returns of the stock market due to abstract fears of a bear market.
In this article: JNJ Also: GILD
Read
1 to 16 of 2652 Posts
1 2 3 ... 166